LifeMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	250.09	212.45	152.55	119.03	92.88	37.29
Revenue Growth (YoY)	28.78%	39.27%	28.16%	28.16%	149.04%	199.10%
Cost of Revenue	32.91	24.07	18.9	18.67	18	8.86
Gross Profit	217.18	188.39	133.65	100.37	74.88	28.43
Selling, General & Admin	199.93	187.1	136.64	131.23	124.96	84.74
Research & Development	10.68	9.51	6.06	2.97	0.95	0.45
Other Operating Expenses	9.73	7.92	5.44	5.85	3.27	1.07
Operating Expenses	220.34	204.53	148.14	140.05	129.18	86.25
Operating Income	-3.16	-16.14	-14.49	-39.69	-54.3	-57.82
Interest Expense	-2.17	-2.18	-2.6	-1.28	-3.02	-1.67
EBT Excluding Unusual Items	-5.32	-18.33	-17.09	-40.96	-57.32	-59.49
Impairment of Goodwill	-	-	-	-8	-	-
Asset Writedown	-	-	-	-0.86	-	-
Other Unusual Items	-1.16	-	-0.33	5.16	-4	-0.91
Pretax Income	-6.48	-18.33	-17.41	-44.66	-61.32	-60.4
Income Tax Expense	0.34	0.4	0.43	0.36	0.01	0.12
Earnings From Continuing Operations	-6.82	-18.73	-17.84	-45.02	-61.32	-60.52
Net Income to Company	-6.82	-18.73	-17.84	-45.02	-61.32	-60.52
Minority Interest in Earnings	-1.2	-0.15	-2.76	-0.51	0.43	1.88
Net Income	-8.02	-18.88	-20.6	-45.54	-60.9	-58.65
Preferred Dividends & Other Adjustments	3.11	3.11	3.11	3.11	0.87	4.72
Net Income to Common	-11.13	-21.99	-23.7	-48.64	-61.77	-63.36
Shares Outstanding (Basic)	44	41	34	31	27	14
Shares Outstanding (Diluted)	44	41	34	31	27	14
Shares Change (YoY)	10.44%	21.50%	9.46%	14.69%	89.20%	44.23%
EPS (Basic)	-0.25	-0.53	-0.70	-1.57	-2.29	-4.44
EPS (Diluted)	-0.25	-0.53	-0.70	-1.57	-2.29	-4.44
Free Cash Flow	10.69	16.02	8.62	-23.3	-33.33	-12.13
Free Cash Flow Per Share	0.24	0.39	0.25	-0.75	-1.23	-0.85
Gross Margin	86.84%	88.67%	87.61%	84.32%	80.62%	76.24%
Operating Margin	-1.26%	-7.60%	-9.50%	-33.34%	-58.47%	-155.04%
Profit Margin	-4.45%	-10.35%	-15.54%	-40.86%	-66.51%	-169.90%
Free Cash Flow Margin	4.28%	7.54%	5.65%	-19.58%	-35.89%	-32.53%
EBITDA	-1.36	-14.67	-13.31	-38.6	-53.95	-57.48
EBITDA Margin	-0.55%	-6.91%	-8.73%	-32.43%	-58.08%	-154.14%
D&A For EBITDA	1.8	1.47	1.18	1.09	0.36	0.34
EBIT	-3.16	-16.14	-14.49	-39.69	-54.3	-57.82
EBIT Margin	-1.26%	-7.60%	-9.50%	-33.34%	-58.47%	-155.04%
Revenue as Reported	250.09	212.45	152.55	119.03	92.88	37.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q